nodes	percent_of_prediction	percent_of_DWPC	metapath
Sevoflurane—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.134	0.277	CbGbCtD
Sevoflurane—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0871	0.18	CbGbCtD
Sevoflurane—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.0759	0.157	CbGbCtD
Sevoflurane—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0373	0.0772	CbGbCtD
Sevoflurane—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.0372	0.0769	CbGbCtD
Sevoflurane—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0288	0.0596	CbGbCtD
Sevoflurane—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0268	0.0554	CbGbCtD
Sevoflurane—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.025	0.0517	CbGbCtD
Sevoflurane—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0123	0.0254	CbGbCtD
Sevoflurane—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0113	0.0233	CbGbCtD
Sevoflurane—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00768	0.0159	CbGbCtD
Sevoflurane—GABRQ—nerve—peripheral nervous system neoplasm	0.00593	0.0753	CbGeAlD
Sevoflurane—GRIA1—nerve—peripheral nervous system neoplasm	0.00537	0.0681	CbGeAlD
Sevoflurane—GRIA1—ganglion—peripheral nervous system neoplasm	0.0053	0.0673	CbGeAlD
Sevoflurane—KCNA1—nerve—peripheral nervous system neoplasm	0.00524	0.0665	CbGeAlD
Sevoflurane—GABRG1—ganglion—peripheral nervous system neoplasm	0.00409	0.0519	CbGeAlD
Sevoflurane—ATP2C1—nerve—peripheral nervous system neoplasm	0.00367	0.0466	CbGeAlD
Sevoflurane—KCNK10—brainstem—peripheral nervous system neoplasm	0.00317	0.0402	CbGeAlD
Sevoflurane—KCNK9—brainstem—peripheral nervous system neoplasm	0.00315	0.04	CbGeAlD
Sevoflurane—GABRA2—ganglion—peripheral nervous system neoplasm	0.00274	0.0347	CbGeAlD
Sevoflurane—KCNA1—trigeminal ganglion—peripheral nervous system neoplasm	0.00254	0.0323	CbGeAlD
Sevoflurane—GRIA1—brainstem—peripheral nervous system neoplasm	0.0023	0.0292	CbGeAlD
Sevoflurane—KCNA1—brainstem—peripheral nervous system neoplasm	0.00225	0.0285	CbGeAlD
Sevoflurane—ATP5D—trigeminal ganglion—peripheral nervous system neoplasm	0.0018	0.0229	CbGeAlD
Sevoflurane—ATP2C1—trigeminal ganglion—peripheral nervous system neoplasm	0.00178	0.0226	CbGeAlD
Sevoflurane—GABRA6—brainstem—peripheral nervous system neoplasm	0.00177	0.0225	CbGeAlD
Sevoflurane—ATP5D—parotid gland—peripheral nervous system neoplasm	0.0017	0.0216	CbGeAlD
Sevoflurane—ATP2C1—parotid gland—peripheral nervous system neoplasm	0.00168	0.0213	CbGeAlD
Sevoflurane—ATP5D—brainstem—peripheral nervous system neoplasm	0.0016	0.0203	CbGeAlD
Sevoflurane—KCNK10—cerebellum—peripheral nervous system neoplasm	0.00156	0.0198	CbGeAlD
Sevoflurane—KCNK9—cerebellum—peripheral nervous system neoplasm	0.00155	0.0197	CbGeAlD
Sevoflurane—GABRG2—trigeminal ganglion—peripheral nervous system neoplasm	0.00147	0.0187	CbGeAlD
Sevoflurane—GABRE—trigeminal ganglion—peripheral nervous system neoplasm	0.00133	0.0169	CbGeAlD
Sevoflurane—GABRB2—brainstem—peripheral nervous system neoplasm	0.0013	0.0165	CbGeAlD
Sevoflurane—GABRA2—brainstem—peripheral nervous system neoplasm	0.00119	0.0151	CbGeAlD
Sevoflurane—GABRA1—brainstem—peripheral nervous system neoplasm	0.00115	0.0146	CbGeAlD
Sevoflurane—GRIA1—cerebellum—peripheral nervous system neoplasm	0.00114	0.0144	CbGeAlD
Sevoflurane—GABRB3—trigeminal ganglion—peripheral nervous system neoplasm	0.00113	0.0143	CbGeAlD
Sevoflurane—KCNA1—cerebellum—peripheral nervous system neoplasm	0.00111	0.0141	CbGeAlD
Sevoflurane—GABRD—cerebellum—peripheral nervous system neoplasm	0.000911	0.0116	CbGeAlD
Sevoflurane—GABRG1—cerebellum—peripheral nervous system neoplasm	0.000877	0.0111	CbGeAlD
Sevoflurane—GABRA6—cerebellum—peripheral nervous system neoplasm	0.000872	0.0111	CbGeAlD
Sevoflurane—GABRB1—cerebellum—peripheral nervous system neoplasm	0.00085	0.0108	CbGeAlD
Sevoflurane—ATP5D—cerebellum—peripheral nervous system neoplasm	0.000787	0.01	CbGeAlD
Sevoflurane—ATP2C1—cerebellum—peripheral nervous system neoplasm	0.000777	0.00987	CbGeAlD
Sevoflurane—GABRA4—cerebellum—peripheral nervous system neoplasm	0.000767	0.00974	CbGeAlD
Sevoflurane—CYP2A6—cerebellum—peripheral nervous system neoplasm	0.000663	0.00842	CbGeAlD
Sevoflurane—GABRB2—cerebellum—peripheral nervous system neoplasm	0.000642	0.00815	CbGeAlD
Sevoflurane—GABRG2—cerebellum—peripheral nervous system neoplasm	0.000642	0.00815	CbGeAlD
Sevoflurane—GABRA2—cerebellum—peripheral nervous system neoplasm	0.000586	0.00744	CbGeAlD
Sevoflurane—GABRA1—cerebellum—peripheral nervous system neoplasm	0.000567	0.00719	CbGeAlD
Sevoflurane—GABRB3—cerebellum—peripheral nervous system neoplasm	0.000493	0.00626	CbGeAlD
Sevoflurane—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000473	0.0012	CcSEcCtD
Sevoflurane—Asthenia—Topotecan—peripheral nervous system neoplasm	0.00047	0.00119	CcSEcCtD
Sevoflurane—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000467	0.00118	CcSEcCtD
Sevoflurane—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000467	0.00118	CcSEcCtD
Sevoflurane—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000466	0.00118	CcSEcCtD
Sevoflurane—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000465	0.00118	CcSEcCtD
Sevoflurane—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.00118	CcSEcCtD
Sevoflurane—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000464	0.00118	CcSEcCtD
Sevoflurane—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000462	0.00117	CcSEcCtD
Sevoflurane—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000461	0.00117	CcSEcCtD
Sevoflurane—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000461	0.00117	CcSEcCtD
Sevoflurane—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00046	0.00117	CcSEcCtD
Sevoflurane—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00046	0.00117	CcSEcCtD
Sevoflurane—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000455	0.00115	CcSEcCtD
Sevoflurane—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000454	0.00115	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000453	0.00115	CcSEcCtD
Sevoflurane—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.00115	CcSEcCtD
Sevoflurane—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000446	0.00113	CcSEcCtD
Sevoflurane—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000446	0.00113	CcSEcCtD
Sevoflurane—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000444	0.00113	CcSEcCtD
Sevoflurane—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.00044	0.00112	CcSEcCtD
Sevoflurane—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000439	0.00111	CcSEcCtD
Sevoflurane—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000438	0.00111	CcSEcCtD
Sevoflurane—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000438	0.00111	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000435	0.0011	CcSEcCtD
Sevoflurane—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000433	0.0011	CcSEcCtD
Sevoflurane—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00043	0.00109	CcSEcCtD
Sevoflurane—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00043	0.00109	CcSEcCtD
Sevoflurane—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00043	0.00109	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000425	0.00108	CcSEcCtD
Sevoflurane—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000421	0.00107	CcSEcCtD
Sevoflurane—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00042	0.00107	CcSEcCtD
Sevoflurane—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00042	0.00107	CcSEcCtD
Sevoflurane—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00042	0.00107	CcSEcCtD
Sevoflurane—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.00106	CcSEcCtD
Sevoflurane—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000417	0.00106	CcSEcCtD
Sevoflurane—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000417	0.00106	CcSEcCtD
Sevoflurane—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000414	0.00105	CcSEcCtD
Sevoflurane—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000413	0.00105	CcSEcCtD
Sevoflurane—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000413	0.00105	CcSEcCtD
Sevoflurane—Rash—Topotecan—peripheral nervous system neoplasm	0.000413	0.00105	CcSEcCtD
Sevoflurane—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000413	0.00105	CcSEcCtD
Sevoflurane—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000412	0.00104	CcSEcCtD
Sevoflurane—Cough—Etoposide—peripheral nervous system neoplasm	0.000411	0.00104	CcSEcCtD
Sevoflurane—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000411	0.00104	CcSEcCtD
Sevoflurane—Headache—Topotecan—peripheral nervous system neoplasm	0.000411	0.00104	CcSEcCtD
Sevoflurane—Rash—Tretinoin—peripheral nervous system neoplasm	0.00041	0.00104	CcSEcCtD
Sevoflurane—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00041	0.00104	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.00041	0.00104	CcSEcCtD
Sevoflurane—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00041	0.00104	CcSEcCtD
Sevoflurane—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00041	0.00104	CcSEcCtD
Sevoflurane—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00041	0.00104	CcSEcCtD
Sevoflurane—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000408	0.00104	CcSEcCtD
Sevoflurane—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000408	0.00104	CcSEcCtD
Sevoflurane—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000408	0.00103	CcSEcCtD
Sevoflurane—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000407	0.00103	CcSEcCtD
Sevoflurane—Headache—Tretinoin—peripheral nervous system neoplasm	0.000407	0.00103	CcSEcCtD
Sevoflurane—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000407	0.00103	CcSEcCtD
Sevoflurane—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000406	0.00103	CcSEcCtD
Sevoflurane—Pain—Vincristine—peripheral nervous system neoplasm	0.000406	0.00103	CcSEcCtD
Sevoflurane—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000405	0.00103	CcSEcCtD
Sevoflurane—Rash—Melphalan—peripheral nervous system neoplasm	0.000405	0.00103	CcSEcCtD
Sevoflurane—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000404	0.00103	CcSEcCtD
Sevoflurane—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000401	0.00102	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000399	0.00101	CcSEcCtD
Sevoflurane—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000392	0.000995	CcSEcCtD
Sevoflurane—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000392	0.000993	CcSEcCtD
Sevoflurane—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000392	0.000993	CcSEcCtD
Sevoflurane—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.00039	0.000988	CcSEcCtD
Sevoflurane—Nausea—Topotecan—peripheral nervous system neoplasm	0.000389	0.000988	CcSEcCtD
Sevoflurane—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000388	0.000984	CcSEcCtD
Sevoflurane—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000386	0.00098	CcSEcCtD
Sevoflurane—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000386	0.00098	CcSEcCtD
Sevoflurane—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000979	CcSEcCtD
Sevoflurane—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000385	0.000976	CcSEcCtD
Sevoflurane—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000381	0.000967	CcSEcCtD
Sevoflurane—Nausea—Melphalan—peripheral nervous system neoplasm	0.000381	0.000967	CcSEcCtD
Sevoflurane—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000377	0.000956	CcSEcCtD
Sevoflurane—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000375	0.000953	CcSEcCtD
Sevoflurane—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000375	0.000952	CcSEcCtD
Sevoflurane—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000951	CcSEcCtD
Sevoflurane—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000374	0.00095	CcSEcCtD
Sevoflurane—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000374	0.000948	CcSEcCtD
Sevoflurane—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000943	CcSEcCtD
Sevoflurane—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000363	0.000921	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000363	0.00092	CcSEcCtD
Sevoflurane—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000359	0.000912	CcSEcCtD
Sevoflurane—Pain—Cisplatin—peripheral nervous system neoplasm	0.000359	0.000911	CcSEcCtD
Sevoflurane—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000355	0.0009	CcSEcCtD
Sevoflurane—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000354	0.000897	CcSEcCtD
Sevoflurane—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00035	0.000888	CcSEcCtD
Sevoflurane—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000349	0.000885	CcSEcCtD
Sevoflurane—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000346	0.000878	CcSEcCtD
Sevoflurane—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000873	CcSEcCtD
Sevoflurane—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000343	0.00087	CcSEcCtD
Sevoflurane—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000868	CcSEcCtD
Sevoflurane—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000342	0.000868	CcSEcCtD
Sevoflurane—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000341	0.000864	CcSEcCtD
Sevoflurane—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000338	0.000857	CcSEcCtD
Sevoflurane—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000335	0.00085	CcSEcCtD
Sevoflurane—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000843	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000332	0.000843	CcSEcCtD
Sevoflurane—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000332	0.000842	CcSEcCtD
Sevoflurane—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000836	CcSEcCtD
Sevoflurane—Pain—Etoposide—peripheral nervous system neoplasm	0.000329	0.000835	CcSEcCtD
Sevoflurane—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000329	0.000834	CcSEcCtD
Sevoflurane—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000328	0.000832	CcSEcCtD
Sevoflurane—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000326	0.000827	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000811	CcSEcCtD
Sevoflurane—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000317	0.000804	CcSEcCtD
Sevoflurane—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000317	0.000803	CcSEcCtD
Sevoflurane—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000316	0.000801	CcSEcCtD
Sevoflurane—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000314	0.000797	CcSEcCtD
Sevoflurane—CYP2E1—cerebellum—peripheral nervous system neoplasm	0.000313	0.00398	CbGeAlD
Sevoflurane—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000313	0.000795	CcSEcCtD
Sevoflurane—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000311	0.000788	CcSEcCtD
Sevoflurane—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00031	0.000788	CcSEcCtD
Sevoflurane—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000309	0.000785	CcSEcCtD
Sevoflurane—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000784	CcSEcCtD
Sevoflurane—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000309	0.000783	CcSEcCtD
Sevoflurane—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.00078	CcSEcCtD
Sevoflurane—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000306	0.000775	CcSEcCtD
Sevoflurane—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000305	0.000774	CcSEcCtD
Sevoflurane—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000305	0.000774	CcSEcCtD
Sevoflurane—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000304	0.000772	CcSEcCtD
Sevoflurane—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000304	0.000771	CcSEcCtD
Sevoflurane—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000304	0.00077	CcSEcCtD
Sevoflurane—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000304	0.00077	CcSEcCtD
Sevoflurane—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000302	0.000766	CcSEcCtD
Sevoflurane—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000301	0.000764	CcSEcCtD
Sevoflurane—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000764	CcSEcCtD
Sevoflurane—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.0003	0.00076	CcSEcCtD
Sevoflurane—Rash—Vincristine—peripheral nervous system neoplasm	0.000299	0.00076	CcSEcCtD
Sevoflurane—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000299	0.000759	CcSEcCtD
Sevoflurane—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000755	CcSEcCtD
Sevoflurane—Headache—Vincristine—peripheral nervous system neoplasm	0.000297	0.000755	CcSEcCtD
Sevoflurane—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000751	CcSEcCtD
Sevoflurane—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000293	0.000743	CcSEcCtD
Sevoflurane—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.000725	CcSEcCtD
Sevoflurane—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000283	0.000719	CcSEcCtD
Sevoflurane—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000282	0.000716	CcSEcCtD
Sevoflurane—Nausea—Vincristine—peripheral nervous system neoplasm	0.000282	0.000716	CcSEcCtD
Sevoflurane—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000715	CcSEcCtD
Sevoflurane—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000712	CcSEcCtD
Sevoflurane—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000712	CcSEcCtD
Sevoflurane—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000279	0.000707	CcSEcCtD
Sevoflurane—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000277	0.000704	CcSEcCtD
Sevoflurane—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000276	0.0007	CcSEcCtD
Sevoflurane—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000275	0.000699	CcSEcCtD
Sevoflurane—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000275	0.000698	CcSEcCtD
Sevoflurane—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000696	CcSEcCtD
Sevoflurane—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000274	0.000694	CcSEcCtD
Sevoflurane—Chills—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000691	CcSEcCtD
Sevoflurane—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000272	0.00069	CcSEcCtD
Sevoflurane—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000688	CcSEcCtD
Sevoflurane—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000267	0.000677	CcSEcCtD
Sevoflurane—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000675	CcSEcCtD
Sevoflurane—Rash—Cisplatin—peripheral nervous system neoplasm	0.000265	0.000672	CcSEcCtD
Sevoflurane—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000265	0.000671	CcSEcCtD
Sevoflurane—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000264	0.00067	CcSEcCtD
Sevoflurane—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000661	CcSEcCtD
Sevoflurane—Tension—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000658	CcSEcCtD
Sevoflurane—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000656	CcSEcCtD
Sevoflurane—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000257	0.000651	CcSEcCtD
Sevoflurane—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000255	0.000646	CcSEcCtD
Sevoflurane—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000254	0.000645	CcSEcCtD
Sevoflurane—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000254	0.000644	CcSEcCtD
Sevoflurane—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000253	0.000642	CcSEcCtD
Sevoflurane—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000252	0.000639	CcSEcCtD
Sevoflurane—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000636	CcSEcCtD
Sevoflurane—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000249	0.000633	CcSEcCtD
Sevoflurane—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000624	CcSEcCtD
Sevoflurane—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000245	0.000621	CcSEcCtD
Sevoflurane—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.00062	CcSEcCtD
Sevoflurane—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000616	CcSEcCtD
Sevoflurane—Rash—Etoposide—peripheral nervous system neoplasm	0.000243	0.000615	CcSEcCtD
Sevoflurane—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000242	0.000615	CcSEcCtD
Sevoflurane—Headache—Etoposide—peripheral nervous system neoplasm	0.000241	0.000611	CcSEcCtD
Sevoflurane—Tension—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000609	CcSEcCtD
Sevoflurane—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000607	CcSEcCtD
Sevoflurane—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000237	0.000602	CcSEcCtD
Sevoflurane—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000237	0.000601	CcSEcCtD
Sevoflurane—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000589	CcSEcCtD
Sevoflurane—Cough—Epirubicin—peripheral nervous system neoplasm	0.000231	0.000585	CcSEcCtD
Sevoflurane—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000229	0.000581	CcSEcCtD
Sevoflurane—Nausea—Etoposide—peripheral nervous system neoplasm	0.000229	0.00058	CcSEcCtD
Sevoflurane—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000228	0.000579	CcSEcCtD
Sevoflurane—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000225	0.000571	CcSEcCtD
Sevoflurane—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.00057	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000223	0.000567	CcSEcCtD
Sevoflurane—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.00022	0.000558	CcSEcCtD
Sevoflurane—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000219	0.000556	CcSEcCtD
Sevoflurane—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000217	0.000552	CcSEcCtD
Sevoflurane—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000547	CcSEcCtD
Sevoflurane—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000547	CcSEcCtD
Sevoflurane—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000545	CcSEcCtD
Sevoflurane—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000541	CcSEcCtD
Sevoflurane—Shock—Epirubicin—peripheral nervous system neoplasm	0.000212	0.000538	CcSEcCtD
Sevoflurane—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000212	0.000537	CcSEcCtD
Sevoflurane—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000537	CcSEcCtD
Sevoflurane—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000536	CcSEcCtD
Sevoflurane—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000211	0.000535	CcSEcCtD
Sevoflurane—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.00021	0.000534	CcSEcCtD
Sevoflurane—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000209	0.000531	CcSEcCtD
Sevoflurane—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000208	0.000528	CcSEcCtD
Sevoflurane—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000524	CcSEcCtD
Sevoflurane—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000204	0.000516	CcSEcCtD
Sevoflurane—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000201	0.000511	CcSEcCtD
Sevoflurane—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.00051	CcSEcCtD
Sevoflurane—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000506	CcSEcCtD
Sevoflurane—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000506	CcSEcCtD
Sevoflurane—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000498	CcSEcCtD
Sevoflurane—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000196	0.000496	CcSEcCtD
Sevoflurane—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000496	CcSEcCtD
Sevoflurane—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000495	CcSEcCtD
Sevoflurane—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000494	CcSEcCtD
Sevoflurane—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.000492	CcSEcCtD
Sevoflurane—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000488	CcSEcCtD
Sevoflurane—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000486	CcSEcCtD
Sevoflurane—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000473	CcSEcCtD
Sevoflurane—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000472	CcSEcCtD
Sevoflurane—GRIA1—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000186	0.00422	CbGpPWpGaD
Sevoflurane—Pain—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000468	CcSEcCtD
Sevoflurane—ND1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000184	0.00419	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000184	0.00419	CbGpPWpGaD
Sevoflurane—ATP2C1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000183	0.00417	CbGpPWpGaD
Sevoflurane—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000458	CcSEcCtD
Sevoflurane—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000451	CcSEcCtD
Sevoflurane—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000451	CcSEcCtD
Sevoflurane—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.00045	CcSEcCtD
Sevoflurane—GABRB3—BDNF signaling pathway—NTRK2—peripheral nervous system neoplasm	0.000175	0.00398	CbGpPWpGaD
Sevoflurane—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.000437	CcSEcCtD
Sevoflurane—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000435	CcSEcCtD
Sevoflurane—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000171	0.000433	CcSEcCtD
Sevoflurane—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00017	0.000432	CcSEcCtD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000167	0.0038	CbGpPWpGaD
Sevoflurane—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000417	CcSEcCtD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000164	0.00374	CbGpPWpGaD
Sevoflurane—KCNK10—Ectoderm Differentiation—MYC—peripheral nervous system neoplasm	0.000164	0.00374	CbGpPWpGaD
Sevoflurane—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000403	CcSEcCtD
Sevoflurane—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000402	CcSEcCtD
Sevoflurane—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.0004	CcSEcCtD
Sevoflurane—GLRA1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000156	0.00354	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000156	0.00354	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000155	0.00354	CbGpPWpGaD
Sevoflurane—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000155	0.000393	CcSEcCtD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000154	0.0035	CbGpPWpGaD
Sevoflurane—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000153	0.000387	CcSEcCtD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000151	0.00343	CbGpPWpGaD
Sevoflurane—ATP2C1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000147	0.00335	CbGpPWpGaD
Sevoflurane—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000373	CcSEcCtD
Sevoflurane—ATP2C1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000144	0.00329	CbGpPWpGaD
Sevoflurane—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000143	0.000363	CcSEcCtD
Sevoflurane—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000362	CcSEcCtD
Sevoflurane—GABRB3—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	0.000142	0.00324	CbGpPWpGaD
Sevoflurane—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000358	CcSEcCtD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000141	0.0032	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.00014	0.0032	CbGpPWpGaD
Sevoflurane—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000348	CcSEcCtD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000136	0.00311	CbGpPWpGaD
Sevoflurane—Rash—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000345	CcSEcCtD
Sevoflurane—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000345	CcSEcCtD
Sevoflurane—Headache—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000343	CcSEcCtD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000134	0.00305	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000133	0.00303	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GNS—peripheral nervous system neoplasm	0.000133	0.00303	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GNS—peripheral nervous system neoplasm	0.000133	0.00303	CbGpPWpGaD
Sevoflurane—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000335	CcSEcCtD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000132	0.003	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000131	0.00298	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.00013	0.00297	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000129	0.00293	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000129	0.00293	CbGpPWpGaD
Sevoflurane—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000128	0.000325	CcSEcCtD
Sevoflurane—GABRG3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000128	0.00291	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—NME1—peripheral nervous system neoplasm	0.000128	0.0029	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—NME1—peripheral nervous system neoplasm	0.000128	0.0029	CbGpPWpGaD
Sevoflurane—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000322	CcSEcCtD
Sevoflurane—GABRB1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000126	0.00287	CbGpPWpGaD
Sevoflurane—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000319	CcSEcCtD
Sevoflurane—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000126	0.000319	CcSEcCtD
Sevoflurane—GLRA1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000125	0.00285	CbGpPWpGaD
Sevoflurane—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000317	CcSEcCtD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000124	0.00282	CbGpPWpGaD
Sevoflurane—GLRA1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000123	0.0028	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—COX2—peripheral nervous system neoplasm	0.000123	0.00279	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—COX2—peripheral nervous system neoplasm	0.000123	0.00279	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000122	0.00278	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000119	0.00271	CbGpPWpGaD
Sevoflurane—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000301	CcSEcCtD
Sevoflurane—GABRA4—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000118	0.00268	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.000117	0.00267	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000116	0.00264	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000116	0.00263	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000114	0.0026	CbGpPWpGaD
Sevoflurane—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000113	0.00258	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000112	0.00256	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.000112	0.00255	CbGpPWpGaD
Sevoflurane—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000108	0.00246	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000108	0.00245	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000105	0.00239	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000105	0.00238	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000104	0.00238	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000103	0.00234	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000101	0.00231	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000101	0.0023	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—BCHE—peripheral nervous system neoplasm	0.0001	0.00228	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	9.95e-05	0.00227	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—BCHE—peripheral nervous system neoplasm	9.85e-05	0.00224	CbGpPWpGaD
Sevoflurane—CYP2A6—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	9.82e-05	0.00223	CbGpPWpGaD
Sevoflurane—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	9.79e-05	0.00223	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	9.78e-05	0.00223	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	9.72e-05	0.00221	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	9.54e-05	0.00217	CbGpPWpGaD
Sevoflurane—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	9.32e-05	0.00212	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	9.08e-05	0.00207	CbGpPWpGaD
Sevoflurane—KCNK18—Neuronal System—HRAS—peripheral nervous system neoplasm	9e-05	0.00205	CbGpPWpGaD
Sevoflurane—CYP2A6—NRF2 pathway—HGF—peripheral nervous system neoplasm	8.9e-05	0.00203	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—BCHE—peripheral nervous system neoplasm	8.61e-05	0.00196	CbGpPWpGaD
Sevoflurane—GRIA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	8.35e-05	0.0019	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	8.34e-05	0.0019	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	8.16e-05	0.00186	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—ENO2—peripheral nervous system neoplasm	8.06e-05	0.00183	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—ENO2—peripheral nervous system neoplasm	8.06e-05	0.00183	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	7.97e-05	0.00181	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	7.53e-05	0.00171	CbGpPWpGaD
Sevoflurane—KCNK10—Neuronal System—HRAS—peripheral nervous system neoplasm	7.34e-05	0.00167	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.31e-05	0.00166	CbGpPWpGaD
Sevoflurane—GRIA1—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	7.21e-05	0.00164	CbGpPWpGaD
Sevoflurane—KCNA1—Neuronal System—HRAS—peripheral nervous system neoplasm	7.12e-05	0.00162	CbGpPWpGaD
Sevoflurane—KCNK2—Neuronal System—HRAS—peripheral nervous system neoplasm	7.02e-05	0.0016	CbGpPWpGaD
Sevoflurane—KCNK3—Neuronal System—HRAS—peripheral nervous system neoplasm	6.82e-05	0.00155	CbGpPWpGaD
Sevoflurane—KCNK9—Neuronal System—HRAS—peripheral nervous system neoplasm	6.82e-05	0.00155	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—BCHE—peripheral nervous system neoplasm	6.81e-05	0.00155	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—BCHE—peripheral nervous system neoplasm	6.81e-05	0.00155	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.56e-05	0.00149	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	6.51e-05	0.00148	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.5e-05	0.00148	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.5e-05	0.00148	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.46e-05	0.00147	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	6.41e-05	0.00146	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—TH—peripheral nervous system neoplasm	6.4e-05	0.00146	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—TH—peripheral nervous system neoplasm	6.4e-05	0.00146	CbGpPWpGaD
Sevoflurane—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	6.33e-05	0.00144	CbGpPWpGaD
Sevoflurane—GABRQ—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	6.29e-05	0.00143	CbGpPWpGaD
Sevoflurane—GRIA1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.28e-05	0.00143	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.11e-05	0.00139	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.04e-05	0.00137	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.89e-05	0.00134	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.77e-05	0.00131	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.52e-05	0.00126	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.36e-05	0.00122	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.28e-05	0.0012	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.27e-05	0.0012	CbGpPWpGaD
Sevoflurane—GABRA1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	5.24e-05	0.00119	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—GNAS—peripheral nervous system neoplasm	5.23e-05	0.00119	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—GNAS—peripheral nervous system neoplasm	5.23e-05	0.00119	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	5.21e-05	0.00119	CbGpPWpGaD
Sevoflurane—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	5.21e-05	0.00119	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.2e-05	0.00118	CbGpPWpGaD
Sevoflurane—GABRG3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.18e-05	0.00118	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.18e-05	0.00118	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.14e-05	0.00117	CbGpPWpGaD
Sevoflurane—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	5.13e-05	0.00117	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—ABCB1—peripheral nervous system neoplasm	5.13e-05	0.00117	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.13e-05	0.00117	CbGpPWpGaD
Sevoflurane—GABRB1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.1e-05	0.00116	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.05e-05	0.00115	CbGpPWpGaD
Sevoflurane—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	4.97e-05	0.00113	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	4.96e-05	0.00113	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.94e-05	0.00112	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.92e-05	0.00112	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.86e-05	0.00111	CbGpPWpGaD
Sevoflurane—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	4.86e-05	0.00111	CbGpPWpGaD
Sevoflurane—GABRA6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.83e-05	0.0011	CbGpPWpGaD
Sevoflurane—GRIA1—Neuronal System—HRAS—peripheral nervous system neoplasm	4.81e-05	0.00109	CbGpPWpGaD
Sevoflurane—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	4.79e-05	0.00109	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	4.78e-05	0.00109	CbGpPWpGaD
Sevoflurane—GABRA4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.77e-05	0.00108	CbGpPWpGaD
Sevoflurane—GABRQ—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	4.76e-05	0.00108	CbGpPWpGaD
Sevoflurane—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	4.47e-05	0.00102	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.44e-05	0.00101	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.41e-05	0.001	CbGpPWpGaD
Sevoflurane—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	4.39e-05	0.000998	CbGpPWpGaD
Sevoflurane—GABRB2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.36e-05	0.000992	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	4.34e-05	0.000988	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.32e-05	0.000982	CbGpPWpGaD
Sevoflurane—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	4.26e-05	0.00097	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.24e-05	0.000965	CbGpPWpGaD
Sevoflurane—GABRA5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.23e-05	0.000964	CbGpPWpGaD
Sevoflurane—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	4.18e-05	0.000952	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.16e-05	0.000948	CbGpPWpGaD
Sevoflurane—GABRA3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.16e-05	0.000947	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.14e-05	0.000942	CbGpPWpGaD
Sevoflurane—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	4.11e-05	0.000936	CbGpPWpGaD
Sevoflurane—GABRA2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.09e-05	0.00093	CbGpPWpGaD
Sevoflurane—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	4.08e-05	0.00093	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.06e-05	0.000925	CbGpPWpGaD
Sevoflurane—GABRB3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	4.06e-05	0.000924	CbGpPWpGaD
Sevoflurane—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	4.01e-05	0.000913	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	3.99e-05	0.000909	CbGpPWpGaD
Sevoflurane—GABRG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.99e-05	0.000908	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.98e-05	0.000906	CbGpPWpGaD
Sevoflurane—GABRG3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.92e-05	0.000892	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.9e-05	0.000888	CbGpPWpGaD
Sevoflurane—GABRB1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.86e-05	0.000878	CbGpPWpGaD
Sevoflurane—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	3.83e-05	0.000872	CbGpPWpGaD
Sevoflurane—GABRA6—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.65e-05	0.000831	CbGpPWpGaD
Sevoflurane—GABRQ—Neuronal System—HRAS—peripheral nervous system neoplasm	3.64e-05	0.00083	CbGpPWpGaD
Sevoflurane—GABRA4—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.6e-05	0.00082	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	3.57e-05	0.000812	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.55e-05	0.000808	CbGpPWpGaD
Sevoflurane—GABRB3—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	3.53e-05	0.000803	CbGpPWpGaD
Sevoflurane—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	3.51e-05	0.000798	CbGpPWpGaD
Sevoflurane—GABRA1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.48e-05	0.000793	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	3.42e-05	0.000779	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.35e-05	0.000763	CbGpPWpGaD
Sevoflurane—GABRB2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.3e-05	0.00075	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	3.29e-05	0.00075	CbGpPWpGaD
Sevoflurane—GABRA5—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.2e-05	0.000729	CbGpPWpGaD
Sevoflurane—GABRA3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.14e-05	0.000716	CbGpPWpGaD
Sevoflurane—GABRA2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.09e-05	0.000704	CbGpPWpGaD
Sevoflurane—GABRB3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.07e-05	0.000699	CbGpPWpGaD
Sevoflurane—GABRG2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	3.02e-05	0.000686	CbGpPWpGaD
Sevoflurane—GABRG3—Neuronal System—HRAS—peripheral nervous system neoplasm	3e-05	0.000683	CbGpPWpGaD
Sevoflurane—GABRB1—Neuronal System—HRAS—peripheral nervous system neoplasm	2.96e-05	0.000673	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	2.9e-05	0.00066	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	2.88e-05	0.000655	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	2.82e-05	0.000642	CbGpPWpGaD
Sevoflurane—GABRA6—Neuronal System—HRAS—peripheral nervous system neoplasm	2.8e-05	0.000637	CbGpPWpGaD
Sevoflurane—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.79e-05	0.000634	CbGpPWpGaD
Sevoflurane—GABRA4—Neuronal System—HRAS—peripheral nervous system neoplasm	2.76e-05	0.000629	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	2.76e-05	0.000628	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	2.7e-05	0.000615	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	2.69e-05	0.000611	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.68e-05	0.00061	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	2.66e-05	0.000605	CbGpPWpGaD
Sevoflurane—GABRA1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	2.64e-05	0.0006	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	2.6e-05	0.000592	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.53e-05	0.000575	CbGpPWpGaD
Sevoflurane—GABRB2—Neuronal System—HRAS—peripheral nervous system neoplasm	2.53e-05	0.000575	CbGpPWpGaD
Sevoflurane—GABRA5—Neuronal System—HRAS—peripheral nervous system neoplasm	2.45e-05	0.000559	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GNS—peripheral nervous system neoplasm	2.42e-05	0.000552	CbGpPWpGaD
Sevoflurane—GABRA3—Neuronal System—HRAS—peripheral nervous system neoplasm	2.41e-05	0.000549	CbGpPWpGaD
Sevoflurane—GABRA2—Neuronal System—HRAS—peripheral nervous system neoplasm	2.37e-05	0.000539	CbGpPWpGaD
Sevoflurane—GABRB3—Neuronal System—HRAS—peripheral nervous system neoplasm	2.35e-05	0.000536	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	2.35e-05	0.000535	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—NME1—peripheral nervous system neoplasm	2.32e-05	0.000529	CbGpPWpGaD
Sevoflurane—GABRG2—Neuronal System—HRAS—peripheral nervous system neoplasm	2.31e-05	0.000526	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	2.24e-05	0.000509	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—COX2—peripheral nervous system neoplasm	2.24e-05	0.000509	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	2.16e-05	0.000492	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.03e-05	0.000463	CbGpPWpGaD
Sevoflurane—GABRA1—Neuronal System—HRAS—peripheral nervous system neoplasm	2.02e-05	0.00046	CbGpPWpGaD
Sevoflurane—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.99e-05	0.000454	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	1.83e-05	0.000416	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.81e-05	0.000412	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	1.74e-05	0.000397	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.74e-05	0.000397	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	1.72e-05	0.000391	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	1.71e-05	0.000389	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.63e-05	0.000372	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	1.47e-05	0.000335	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	1.47e-05	0.000334	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	1.44e-05	0.000329	CbGpPWpGaD
Sevoflurane—ND1—Metabolism—AKT1—peripheral nervous system neoplasm	1.41e-05	0.000321	CbGpPWpGaD
Sevoflurane—ATP5D—Metabolism—AKT1—peripheral nervous system neoplasm	1.41e-05	0.000321	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.41e-05	0.00032	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	1.4e-05	0.000319	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	1.39e-05	0.000315	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.38e-05	0.000313	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.38e-05	0.000313	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	1.36e-05	0.000309	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.31e-05	0.000298	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1.25e-05	0.000286	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	1.24e-05	0.000282	CbGpPWpGaD
Sevoflurane—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	1.23e-05	0.00028	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	1.21e-05	0.000275	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.18e-05	0.000269	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—TH—peripheral nervous system neoplasm	1.17e-05	0.000266	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	1.13e-05	0.000258	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.11e-05	0.000253	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	1.11e-05	0.000252	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.09e-05	0.000247	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	9.81e-06	0.000223	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	9.52e-06	0.000217	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	9.34e-06	0.000213	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	7.93e-06	0.00018	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	7.51e-06	0.000171	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	7.18e-06	0.000163	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	6.7e-06	0.000152	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.39e-06	0.000145	CbGpPWpGaD
Sevoflurane—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	6.34e-06	0.000144	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	6.3e-06	0.000143	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	5.14e-06	0.000117	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	5.04e-06	0.000115	CbGpPWpGaD
Sevoflurane—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	3.78e-06	8.61e-05	CbGpPWpGaD
Sevoflurane—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	3.05e-06	6.95e-05	CbGpPWpGaD
Sevoflurane—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	2.99e-06	6.81e-05	CbGpPWpGaD
Sevoflurane—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	2.57e-06	5.85e-05	CbGpPWpGaD
Sevoflurane—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.39e-06	3.16e-05	CbGpPWpGaD
